Hannah Mamuszka and Lena Chaihorsky introduce the podcast. They discuss the financial misincentives that the U.S. healthcare is built on, which reward treatment over prevention and volume over value, keeping patients from the best data-driven care. Through their own careers in pharma, diagnostics, and laboratory medicine, they explain why data and science so often gets […]

Hannah Mamuszka and Lena Chaihorsky make the case that diagnostics — not just drugs — are the key to controlling healthcare spending, and that the U.S. systematically underuses them. They lay the groundwork for the series: primary diagnosis (what’s actually causing your symptoms), the “diagnosis of exclusion” trap, and two kinds of tests that determine […]

Hannah Mamuszka and Lena Chaihorsky talk with Jane Cheshire Gilbert, the CPA who spent two decades running the health plan for the Teachers’ Retirement System of Kentucky (TRS) and became an unlikely pioneer in pharmacogenomics. Serving tens of thousands of retired teachers — many in their 80s and 90s, on an average of 15 medications […]